CurrentEndo coverage · page 25 of 33
Cardiovascular Diabetology
Latest from Cardiovascular Diabetology
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population
Cross-sectional studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease
Cross-sectional studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study
Cohort studyLipids & liver
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients
Case-control studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
Cohort studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Central and peripheral blood pressures in relation to the triglyceride-glucose index in a Chinese population
Cross-sectional studyLipids & liver
Cardiovasc Diabetol
Cardiovasc Diabetol